Primary care networks (PCNs) will be rewarded for increased prescribing of dry powder inhalers (DPIs) and soft mist inhalers (SMIs) from October 2021, in an effort to reduce inhaler carbon emissions across the NHS. Increased prescribing of salbutamol metered dose inhalers (MDIs) with lower carbon intensity propellant will also be rewarded as part of a suite of incentivised targets for PCNs in 2021/2022 and 2022/2023.
展开▼